aspirin resistance

Clinical Characteristics of Aspirin Resistance in Patients with Cardiovascular Diseases

心血管病患者阿司匹林抵抗的临床特征

A study on the correlation between aspirin resistance and gene polymorphisms

阿司匹林抵抗与基因多态性的相关性研究

Aspirin resistance may increase the risk of cardiovascular events .

阿司匹林抵抗程度的增强可能与心血管事件风险的增加独立相关。

The Influence of Aspirin Resistance by Diabetes and Correlative Analysis

糖尿病对小剂量阿司匹林治疗的阿司匹林抵抗的影响及相关因素分析

Aspirin resistance in the elderly and its associated clinical factors

老年人群阿司匹林抵抗及其临床相关因素分析

Heart Rate Variability in Patients With Stable Coronary Artery Disease and Aspirin Resistance

冠心病患者心率变异性与阿司匹林抵抗的研究

Regulatory mechanism of cellular iron metabolism on aspirin resistance to oxidative damage

细胞铁代谢变化参与阿司匹林抗氧化作用的调控机制

There is no specific therapy for aspirin resistance .

阿司匹林抵抗尚无特异性治疗方法。

Aspirin resistance in patients taking small dose of aspirin

服用小剂量阿司匹林患者的阿司匹林抵抗

Prevalence of aspirin resistance in Harbin patients with cardiovascular and cerebral disease

哈尔滨地区心脑血管病患者中阿司匹林抵抗的探讨

Study of Tip Resistance on Rock Socketed Pile Aspirin Resistance

嵌岩桩桩端承载力探讨阿司匹林抵抗的研究

Conclusion Aspirin resistance ( AR ) was really shown , which should cause close attention .

结论阿司匹林抵抗（AR）在男性冠心病患者中确实存在，应引起关注。

Clinical trials have shown that laboratory aspirin resistance is correlated with vascular events .

多项临床试验证实，实验室阿司匹林抵抗和临床血管事件相关。

Results Of302 cases , 58 cases developed aspirin resistance ( 19.2 % ) .

结果302例患者中58例存在阿司匹林抵抗，占19.2%。

Platelet Complement C4d and Aspirin Resistance in Patients with Acute Ischemic Stroke

急性缺血性卒中患者阿司匹林抵抗与血小板补体C4d的相关性研究

Aspirin Resistance & A Very Important Factor That Can ′ t be Ignored in Treatment of Cardiovascular Disease

阿司匹林抵抗&治疗心血管疾病中不容忽视的因素

Morbidity rate and clinical feature of aspirin resistance and its risk factors in elderly patients with coronary artery disease

老年冠心病患者阿司匹林抵抗的临床研究

Correlation study of urinary 11-dehydro-thromboxane B_2 and aspirin resistance in elderly patients

老年人尿11-脱氢血栓素B2和阿司匹林抵抗的相关性研究

Effect of compound Danshen dropping pills on platelet aggregation ratio in patients with aspirin resistance

复方丹参滴丸在阿司匹林抵抗患者治疗中血小板聚集率的研究

Pathogenesis and prevention tactics of aspirin resistance

阿司匹林抵抗的产生机制与防治策略

Conclusion Tongxinluo may reduce platelet aggregation rate and produce certain therapeutic effect for the patients with aspirin resistance .

结论通心络可以降低血小板聚集率，对于阿司匹林抵抗患者，选用通心络治疗可以取得一定的疗效。

Continuous enhancement of platelet activation in elderly patients after thrombolysis maybe related to aspirin resistance in elderly .

因此溶栓后应加强抗血小板治疗，溶栓后老年人这种血小板活性持续增强可能与溶栓后更易造成老年阿司匹林抵抗有关。

The impact of aspirin resistance on preventing thromboembolic cardiovascular desease

阿司匹林抵抗对血栓栓塞性心血管疾病预防效果的影响

The reason for aspirin resistance may be the drug dose used incorrectly and COX-1 enzyme genetic polymorphism .

阿司匹林抵抗的可能原因包括用量不当、药物相互作用、环氧合酶-1的遗传多态性和涉及血栓素生物合成的其他基因、血栓素生物合成的非血小板源性因素的上调和血小板更新增强。

Association of the Cyclooxygenase-2 765G / C Gene Polymorphism with Aspirin Resistance in Patients of Coronary Heart Disease

COX-2基因765G>C多态性与冠心病患者阿司匹林抵抗的相关性研究

Objective : To study aspirin resistance ( AR ) and evaluate its clinical characteristics in the aspirin-treated patients with coronary artery disease .

目的：本研究旨在探讨新疆医科大学第一附属医院住院冠状动脉粥样硬化性心脏病（冠心病）患者中发生阿司匹林抵抗（AR）的现状及临床特点。

Objective : To study the effect of combine treatment on aspirin resistance ( AR ) in patients with acute coronary syndrome ( ACS ) .

目的：探讨联合治疗对冠脉综合征（ACS）患者阿司匹林抵抗（AR）的疗效。

Objective To explore the effect of clopidogrel bisulfate on aspirin resistance ( AR ) in patients with ischemic cerebrovascular disease .

目的观察氯吡格雷对缺血性脑血管病患者阿司匹林抵抗（AR）的影响。

Objective To evaluate the prevalence of aspirin resistance in patients with cerebral infarction and to analyse the clinical predictors of aspirin resistance .

目的评价脑梗死患者阿司匹林抵抗（AR）发生的情况，分析其临床有关因素，探讨可能机制。

Objective To study the prospectively prevalence of aspirin resistance in harbin patients with cardiovascular and cerebral disease and clinical predictors of aspirin resistance .

目的研究哈尔滨地区心脑血管病患者中发生阿司匹林抵抗（AR）概况，并探讨其预测因子。